×
About 4,918 results

ALLMedicine™ Helicobacter Pylori Infection Center

Research & Reviews  1,732 results

Worldwide and Regional Efficacy Estimates of First-line Helicobacter pylori Treatments:...
https://doi.org/10.1097/MCG.0000000000001641
Journal of Clinical Gastroenterology; Zamani M, Alizadeh-Tabari S et. al.

Dec 3rd, 2021 - Eradication of Helicobacter pylori infection is challenging. We aimed to determine the optimal first-line H. pylori treatments at global and regional levels. We searched Embase, PubMed, Cochrane CENTRAL, Web of Science, Scopus, WHO ICTRP, Clinical...

Effect of sequential eradication therapy on serum osteoprotegerin levels in patients wi...
https://doi.org/10.1177/03000605211060648
The Journal of International Medical Research; Murad H, Rafeeq M et. al.

Dec 2nd, 2021 - To investigate the effect of sequential Helicobacter pylori eradication therapy on serum osteoprotegerin levels in patients with H. pylori infection and co-existing inflammatory bowel disease (IBD). Three groups of patients were involved in this o...

Helicobacter pylori infection and the progression of atherosclerosis: A systematic revi...
https://doi.org/10.1111/hel.12865
Helicobacter Shi H, Li Y et. al.

Nov 30th, 2021 - In recent years, many studies have tried to prove whether Helicobacter pylori (H. pylori) can promote the progression of atherosclerosis (AS), but the reported results are conflicting. Carotid intima-media thickness (CIMT), flow-mediated dilation ...

Chinese Consensus Report on Family-Based Helicobacter pylori Infection Control and Mana...
https://doi.org/10.1136/gutjnl-2021-325630
Gut Ding SZ, Du YQ et. al.

Nov 28th, 2021 - Helicobacter pylori infection is mostly a family-based infectious disease. To facilitate its prevention and management, a national consensus meeting was held to review current evidence and propose strategies for population-wide and family-based H....

Systematic review with meta-analysis: environmental and dietary differences of inflamma...
https://doi.org/10.1111/apt.16703
Alimentary Pharmacology & Therapeutics; Zhao M, Feng R et. al.

Nov 26th, 2021 - While the incidence of inflammatory bowel disease (IBD) has stabilised in the West, it is still increasing in several newly industrialised countries. To investigate whether the environmental and dietary risk factors for IBD differ between Eastern ...

see more →

Guidelines  7 results

AGA Clinical Practice Update on the Diagnosis and Management of Atrophic Gastritis: Exp...
https://doi.org/10.1053/j.gastro.2021.06.078
Gastroenterology Shah SC, Piazuelo MB et. al.

Aug 30th, 2021 - The purpose of this Clinical Practice Update Expert Review is to provide clinicians with guidance on the diagnosis and management of atrophic gastritis, a common preneoplastic condition of the stomach, with a primary focus on atrophic gastritis du...

AGA Clinical Practice Update on the Management of Refractory Helicobacter pylori Infect...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8281326
Gastroenterology Shah SC, Iyer PG et. al.

Feb 2nd, 2021 - The purpose of this CPU Expert Review is to provide clinicians with guidance on the management of Helicobacter pylori after an initial attempt at eradication therapy fails, including best practice advice on specific regimen selection, and consider...

British Society of Gastroenterology guidelines on the diagnosis and management of patie...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6709778
Gut Banks M, Graham D et. al.

Jul 7th, 2019 - Gastric adenocarcinoma carries a poor prognosis, in part due to the late stage of diagnosis. Risk factors include Helicobacter pylori infection, family history of gastric cancer-in particular, hereditary diffuse gastric cancer and pernicious anaem...

Joint ESPGHAN/NASPGHAN Guidelines for the Management of Helicobacter pylori in Children...
https://doi.org/10.1097/MPG.0000000000001594
Journal of Pediatric Gastroenterology and Nutrition; Jones NL, Koletzko S et. al.

May 26th, 2017 - Because of the changing epidemiology of Helicobacter pylori infection and low efficacy of currently recommended therapies, an update of the European Society for Paediatric Gastroenterology Hepatology and Nutrition/North American Society for Pediat...

ACG Clinical Guideline: Treatment of Helicobacter pylori Infection.
https://doi.org/10.1038/ajg.2016.563
The American Journal of Gastroenterology; Chey WD, Leontiadis GI et. al.

Jan 11th, 2017 - Helicobacter pylori (H. pylori) infection is a common worldwide infection that is an important cause of peptic ulcer disease and gastric cancer. H. pylori may also have a role in uninvestigated and functional dyspepsia, ulcer risk in patients taki...

see more →

Drugs  59 results see all →

Clinicaltrials.gov  49 results

Efficacy and Safety of 14-day Concomitant Therapy for Refractory Helicobacter Pylori Infection
https://clinicaltrials.gov/ct2/show/NCT05133193

Nov 26th, 2021 - Helicobacter pylori infects half of the world's population. H.pylori eradication is an effective approach to reduce the risk of developing gastric cancer. However, eradication rates of first-line therapy decreased over years due to the rapidly inc...

Helicobacter Pylori First-line Treatment Containing Tetracycline in Patients Allergic to Penicillin
https://clinicaltrials.gov/ct2/show/NCT05129176

Nov 24th, 2021 - Helicobacter pylori(H.pylori), which infects about 50% of the global population, has been recognized as a main risk factor of multiple gastric pathologies, especially non-cardiac gastric cancer. Strongly evidence supports that H.pylori eradication...

Helicobacter Pylori First-line Treatment in Patients Allergic to Penicillin
https://clinicaltrials.gov/ct2/show/NCT04122287

Nov 18th, 2021 - Helicobacter pylori(H.pylori), which infects about 50% of the global population, has been recognized as a main risk factor of multiple gastric pathologies, especially non-cardiac gastric cancer. Strongly evidence supports that H.pylori eradication...

Helicobacter Pylori Rescue Treatment Containing Tetracycline in Patients Allergic to Penicillin
https://clinicaltrials.gov/ct2/show/NCT04264663

Nov 18th, 2021 - Helicobacter pylori(H.pylori), which infects about 50% of the global population, has been recognized as a main risk factor of multiple gastric pathologies, especially non-cardiac gastric cancer. Strongly evidence supports that H.pylori eradication...

Differences in the Eradication of Helicobacter Pylori by Different Therapies
https://clinicaltrials.gov/ct2/show/NCT05097846

Nov 4th, 2021 - A single-center, prospective, open-label, parallel control design was conducted to enroll 100 patients with confirmed Helicobacter pylori infection. Patients were randomly divided into four groups, respectively accept four treatment regimens inclu...

see more →

News  118 results

OPT-PEACE Calls Out GI Injuries With Post-PCI Antiplatelets
https://www.medscape.com/viewarticle/962697

Nov 10th, 2021 - A novel noninvasive endoscopy trial lends further support for the safety of single antiplatelet therapy after a 6-month course of dual antiplatelet therapy (DAPT) in patients undergoing percutaneous coronary intervention (PCI). Results from the OP...

Vonoprazan beats PPIs in H. pylori eradication
https://www.mdedge.com/internalmedicine/article/248053/gastroenterology/vonoprazan-beats-ppis-h-pylori-eradication
Jim Kling

Oct 28th, 2021 - LAS VEGAS – In the treatment of Helicobacter pylori infection, combination therapies using the oral potassium-competitive acid blocker vonoprazan were superior to standard proton pump inhibitor (PPI)–based triple therapy, producing higher eradicat.

Diagnosing and Managing Atrophic Gastritis: Expert Review
https://www.medscape.com/viewarticle/961530

Oct 25th, 2021 - A new clinical practice update expert review for the diagnosis and management of atrophic gastritis (AG) from the American Gastroenterological Association focuses on cases linked to Helicobacter pylori infection or autoimmunity. Dr Shailja C. Shah...

AGA Clinical Practice Update: Expert review on atrophic gastritis
https://www.mdedge.com/internalmedicine/article/247498/gastroenterology/aga-clinical-practice-update-expert-review-atrophic
Jim Kling

Oct 18th, 2021 - A new clinical practice update expert review for the diagnosis and management of atrophic gastritis (AG) from the American Gastroenterological Association focuses on cases linked to Helicobacter pylori infection or autoimmunity. Dr.

Gastric cancer: Family history–based H. pylori strategy would be cost effective
https://www.mdedge.com/internalmedicine/article/246539/gastroenterology/gastric-cancer-family-history-based-h-pylori
Jim Kling

Sep 23rd, 2021 - Testing for and treating Helicobacter pylori infection among individuals with a family history of gastric cancer could be a cost-effective strategy in the United States, according to a new model published in the journal Gastroenterology. sgame/thi.

see more →

Patient Education  2 results see all →